We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

HUMAN GMBH

HUMAN offers a broad portfolio of in vitro diagnostic products with more than 400 products in 12 areas covering the w... read more Featured Products: More products

Download Mobile App





HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments

By LabMedica International staff writers
Posted on 04 Feb 2025

HUMAN Diagnostics (Wiesbaden, Germany) is launching its next-generation clinical chemistry instruments at Medlab Middle East 2025. More...

The launch is under the motto “Primed for Precision. Built for Performance” and will spotlight the next-generation HumaStar 300SR, HumaStar 200, and the HumaLyzer Primus NG, offering laboratories cutting-edge performance, enhanced efficiency, and robust reliability. These instruments cater to diverse throughput needs, empowering labs to deliver accurate and timely results critical to patient care.

The updated HumaStar 300SR and HumaStar 200 instruments offer improved performance and reliability with an advanced cuvette wash station and, now new, clot detection (HumaStar 300SR only). The upgraded pipetting unit ensures higher precision for low volumes and better repeatability, while V-shaped reaction cuvettes reduce reagent use and operating costs. Additionally, an integrated 2D barcode scanner simplifies the import of QC and calibration target values, streamlining operations; the 3-color LED status illumination provides intuitive and easy monitoring.

The HumaLyzer Primus NG is a user-friendly, semi-automated solution that is ideal for laboratories in resource-limited settings with a large 7-inch touchscreen interface enhancing usability. Visitors to HUMAN’s booth can explore these next-gen instruments and view live demonstrations that showcase their capabilities and ease of use. Additionally, HUMAN is also showcasing the HumaCombilyzer portable, semi-automated urine test strip analyzer which is ideal for in-office and more rural healthcare settings. Alongside, HUMAN is showcasing HumaCombina urine test strips which enable fast and effortless assessment of urine status, supporting the detection of pathological changes.

“HUMAN’s clinical chemistry instruments have long been trusted for their precision and reliability. With this launch, we’re setting new standards for laboratory diagnostics by combining German engineering excellence with the latest technological advancements,” said Dr. Christine Hettmann-Dreuw, VP of Marketing & Strategic Purchase at HUMAN Diagnostics.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.